McDonald's nose dives, Merck's $8.4B Cubist deal & Gross juices Janus
McDonald's (MCD) is on the down trend today. It's the worst stock of the session in the Dow Jones Industrial Average (^DJI), down over 3%. The fast food giant said U.S. sales fell nearly 5% in November. In fact, every region experienced a drop. Sales slipped 2% in Europe and 4% in the Asia-Pacific and Middle East regions. CEO Don Thompson telling investors the fast-food giant is working to regain momentum and relevance however investors are not too confident he has the right ingredients for a turnaround.
Get the Latest Market Data and News with the Yahoo Finance App
Another Dow Member, Merck (MRK), is spending $8.4 billion for Cubist (CBST), the maker of antibiotics for infectious diseases. Cubists shares are soaring over 30%, roughly the premium paid for the deal which will add $1 billion to Merck's revenue next year and will contribute to earnings in 2016. Merck has been chasing more targeted deals over larger scale acquisitions. Merck shares are little changed on the news.
Finally, bond king Bill Gross is giving Janus (JNS) an early holiday gift. Assets in his new fund, Janus Global Unconstrained Bond fund (JUCIX), hit $1.2 billion in November. Janus shares jumping on the news. Inflows during the month totaled $770 million, the largest yet according to Morningstar. Gross and his former employer PIMCO had an acrimonious split this fall which has been widely publicized. The debacle has cost PIMCO about $60 billion in assets, many of which are being deployed to firms such as BlackRock (BLK) and Vanguard. Gross formerly ran PIMCO's Total Return Fund (PTTRX).
More From Yahoo Finance:
Europe's dysfunction makes for more trading opportunities
How to trade like the world's biggest hedge fund
Inequality casts a shadow over stock market records